Comparison of Two Types of Artificial Tears
Launched by THE NORWEGIAN DRY EYE CLINIC · Apr 26, 2022
Trial Information
Current as of September 30, 2025
Unknown status
Keywords
ClinConnect Summary
The patients will be treated with Thealoz Duo (at least 3 times daily) in one eye and with Hyabak (at least 3 times daily) in the other eye, based on randomization table. Both Hyabak and Thealoz Duo are preservative free. The doctors who examine the patients will not get any information about the choice of artificial tears in each eye. Besides the artificial tears, if necessary, the patients will receive other treatments, for instance, steroids, cyclosporine etc., according to their dry eye severity.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Dry Eye Severity Level (DESL) 1-3
- • Equivalent between-eye DESL
- Exclusion Criteria:
- • Ocular infection and/or non-linked inflammation
- • Corneal pathology (except KSP)
- • Corneal refractive surgery or cataract surgery within 6 months prior to the study
About The Norwegian Dry Eye Clinic
The Norwegian Dry Eye Clinic is a leading clinical research organization dedicated to advancing the understanding and treatment of dry eye disease. With a focus on innovative therapies and patient-centered care, the clinic conducts rigorous clinical trials aimed at evaluating the safety and efficacy of new treatments. Committed to excellence in research and patient outcomes, the Norwegian Dry Eye Clinic collaborates with healthcare professionals and academic institutions to enhance therapeutic options and improve quality of life for individuals suffering from dry eye conditions. Through its comprehensive approach and expertise in ophthalmology, the clinic is at the forefront of dry eye research in Norway and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, Norway
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials